New appointments bring global expertise in commercial strategy, manufacturing excellence, and entrepreneurial leadership to Chanelle’s Board
Ireland, October 01, 2025 – Chanelle Pharma (“Chanelle”), Ireland’s largest indigenous pharmaceutical company and a leading manufacturer of generic pharmaceuticals for human and animal health, today announced the appointment of Steven Mahoney, Rafik Amrane, and Jean Hoffman to its Board of Directors, effective immediately.
Steven, Rafik, and Jean will bring decades of global leadership experience across healthcare, manufacturing, and entrepreneurship, further strengthening Chanelle’s governance framework and supporting the company’s ambitious growth in both veterinary and human health markets.
Carsten Hellmann, Chair of the Board at Chanelle Pharma, said: “Steven, Rafik, and Jean each bring unique perspectives and decades of global leadership, especially in the Animal Health space. Their broad international experience will deepen the Board’s strategic insight and strengthen our ability to building a strong Chanelle platform.”
Angelo Gatto, CEO and Board Member of Chanelle Pharma, added: “The addition of these distinguished professionals brings to Chanelle world-class expertise that will help us scale faster, innovate smarter, and deepen our impact across global markets. Their vast knowledge and experience will be instrumental as we continue our growth journey.”
Steven Mahoney is a seasoned healthcare executive with 35 years’ experience. He spent most of his career at Merial where he held key leadership roles across Asia Pacific, the U.S. and Latin America focusing on regional strategy, commercial operations, and integration. His expertise in managing complex global teams and driving growth in regulated markets aligns directly with Chanelle’s international ambitions.
Rafik Amrane currently leads Global Operations at Opella, a 5 Billion Euro turnover HealthCare company, overseeing Manufacturing, Supply Chain and Quality across 13 manufacturing sites, 140 CMOs and more than 5,000 professionals worldwide. His background includes transformational leadership roles at Toyota, Merial and Sanofi, bringing deep operational insight and a strong track record in driving manufacturing excellence and supply chain innovation. Rafik has also led large scale performance transformation in various industries at McKinsey & Co. Jean Hoffman is an accomplished entrepreneur and board director who has successfully built and exited two healthcare companies, including Putney Inc., a leading U.S. generic veterinary pharmaceutical firm acquired for $200 million. Jean’s expertise spans portfolio strategy, commercial growth and governance, providing Chanelle with valuable experience in scaling high-growth businesses.
For further information, please contact:
Anna Maria Barry ambarry@chanellegroup.ie I +353 (0)86 227 2072
Seán Lawless chanelle@sodali.com | +353 (0)85 116 7640
About Chanelle Pharma Headquartered in Loughrea, Co. Galway, Chanelle is Ireland’s largest manufacturer of generic pharmaceuticals for human and animal health. With operations in Ireland, the UK, Portugal, and Jordan, Chanelle’s manufacturing and R&D facilities meet the highest regulatory standards. Its global supply chain and distribution network exports to almost 90 countries. In April 2024, Chanelle was acquired by Exponent PE, a leading European private equity firm, marking a new chapter of strategic growth.
